SCHEMBL2993650

SCHEMBL2993650

C[C@@H]1CCCC[C@@H]1N1CCC(Cc2ccc(Br)cc2Cl)C1=O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 3/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
P2RX7 Q99572 3/20 0.34
OPRM1 P35372 2/20 0.33
PDE2A O00408 1/20 0.33
LMNA P02545 3/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HCAR1 Q9BXC0 1/20 0.33
ALDH1A1 P00352 2/20 0.32
NPC1 O15118 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2991864 1.00 HSD11B1 (0.38) HSD11B1SMN1; SMN2L3MBTL1KDM4ETAS1R3
SCHEMBL2991629 1.00 HSD11B1 (0.38) HSD11B1SMN1; SMN2L3MBTL1KDM4ETAS1R3
SCHEMBL2993742 0.88 SIGMAR1 (0.42) HSD11B1KDM4EP2RX7ALDH1A1KMT2A
SCHEMBL2993740 0.88 SIGMAR1 (0.42) HSD11B1KDM4EP2RX7ALDH1A1KMT2A
SCHEMBL2993737 0.88 SIGMAR1 (0.42) HSD11B1KDM4EP2RX7ALDH1A1KMT2A
SCHEMBL13955036 0.86 HSD11B1 (0.38) HSD11B1SMN1; SMN2TAS1R3TAS1R1P2RX7
SCHEMBL2990822 0.86 HSD11B1 (0.54) HSD11B1SMN1; SMN2KDM4EP2RX7OPRM1
SCHEMBL2999700 0.81 ROCK2 (0.37) HSD11B1TAS1R3TAS1R1HCAR1
Hydrochloric Acid SCHEMBL3885742 0.81 ROCK2 (0.37) HSD11B1HCAR1
SCHEMBL2991334 0.80 HSD11B1 (0.47) HSD11B1SMN1; SMN2L3MBTL1KDM4EP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100184764-A1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2010-07-22 US claimed
EP-1807072-B1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2009-01-07 EP claimed
US-20080275043-A1 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-11-06 US claimed
US-20100184764-A1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2010-07-22 US disclosed
US-7713979-B2 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2010-05-11 US disclosed
EP-1807072-B1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2009-01-07 EP disclosed
US-20080275043-A1 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275043-A1 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1 HSD11B1, HSDL2, HSD17B1 HSD11B1 1/4885SMN1; SMN2 4576/4885L3MBTL1 2617/4885
US-20100184764-A1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD3B1 HSD11B1 1/4885SMN1; SMN2 4334/4885L3MBTL1 3585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.